Endometrial Mucinous Adenocarcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Endometrial Mucinous Adenocarcinoma

subtype

Identifier: CI-CAN-00005165
Entity page: /cancer/endometrial-mucinous-adenocarcinoma ↗
Edges: 17

Neighbours: 9 drugs8 trials
Drawn: 17 of 17 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Endometrial Mucinous Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived9 of 9
→ investigated in trials for	Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Endometrial Mucinous Adenocarcinoma studied in …STUDIED_INderived8 of 8
→ studied in	NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00492778Phase 2 · unknown Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01440998Phase 1 · completed Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01642082Phase 2 · completed Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00888173Phase 2 · completed Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01225887Phase 2 · completed Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Endometrial Mucinous Adenocarcinoma	1	Observed	clinicaltrials	graph →